Jump to content

New Alzheimers drug has been licensed.


Recommended Posts

3 hours ago, onewheeldave said:

There is a lot of evidence that diet and exercise have a big impact on dementia onset, as well as on a lot of other serious diseases like CHD etc.

 

So, in a sense, the solution already is available, for those willing to change their eating and lifestyle.

 

 

Reducing the probability of Alzheimers by between 20 and 40% (depending on which research papead) is hardly a solution.

 

 

  • Like 1
Link to comment
Share on other sites

2 minutes ago, Longcol said:

 

Reducing the probability of Alzheimers by between 20 and 40% (depending on which research papead) is hardly a solution.

 

 

Should be "paper you read",

 

Oh the joys of a few seconds to correct posts,

Link to comment
Share on other sites

7 hours ago, Anna B said:

Just caught the tail end of this on the lunchtime news, so didn't get the whole report...

 

A new Alzheimers  drug has been licensed for use in the UK, but will not be made available on the NHS.

So I'm assuming it will only be available to those able to pay for it.

 And any clues to what it will cost?

 

Considering Alzheimers / dementia is the biggest (slow and distressing) killer of old people, and arguably the most feared of all the debilitating illnesses, and usually necessitates care in a very expensive care institution,

shouldn't it be made available for everyone who needs it?

 

 

Anna , I agree it should be available for everyone , am going to have to do some research on this drug . Dementia though , doesn't kill people , it's the fact people suffering from it , die from conditions they pick up because this horror of a disease makes people vulnerable to many illnesses . Their vulnerability is immense . My Dad eventually died after getting , C. Diff , Norovirus , bleeding ulcer , These people are so vulnerable 

Link to comment
Share on other sites

3 minutes ago, lavery549@yahoo said:

And it's only available for early stages . 

It only appears to be effective for a few months in the early onset of the disease,

 

https://www.theguardian.com/society/article/2024/aug/22/uk-health-regulator-rejects-lecanemab-as-treatment-for-alzheimers

 

"The drug is not a cure. But in clinical trials, the therapy slowed cognitive decline by 27% in early Alzheimer’s patients, compared with a placebo."

 

"clinical trials showed lecanemab can slow cognitive decline by four to six months, but there was little evidence on its long-term effects. "

 

"It only slows disease progression moderately, and it comes with dangerous side-effects"

 

 

 

 

Link to comment
Share on other sites

Cost was one issue, but there was a smorgasbord of side effects associated with the drug, very regular hospital trips were needed to monitor patients.

 

It's notable that we approved it for use, but the NHS won't buy it.  It was simply rejected by the European Medicines Agency.

 

 

Edited by geared
  • Like 2
Link to comment
Share on other sites

Biggest risk factor for Alzheimers is age,

 

https://www.alzheimers.org.uk/about-dementia/types-dementia/who-gets-alzheimers-disease

 

"Age is the biggest risk factor for Alzheimer’s, as it is for most types of dementia. This means that a person is more likely to get Alzheimer’s as they get older. Above the age of 65, a person’s risk of developing Alzheimer’s doubles about every five years."

 

Now all we need to do is summat to stop us getting older,

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.